Robert Burns
Stock Analyst at HC Wainwright & Co.
(1.22)
# 3,578
Out of 4,896 analysts
476
Total ratings
32.19%
Success rate
-14.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Robert Burns
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KPTI Karyopharm Therapeutics | Assumes: Buy | $27 | $4.60 | +486.96% | 1 | Jul 11, 2025 | |
| COGT Cogent Biosciences | Maintains: Buy | $12 → $22 | $10.91 | +101.65% | 12 | Jul 8, 2025 | |
| REPL Replimune Group | Reiterates: Buy | $22 | $10.85 | +102.76% | 17 | Jul 3, 2025 | |
| ZYME Zymeworks | Reiterates: Neutral | $13 | $13.49 | -3.63% | 21 | Jul 3, 2025 | |
| TLX Telix Pharmaceuticals | Initiates: Buy | $23 | $15.93 | +44.38% | 1 | Jul 3, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $40 → $48 | $22.39 | +114.38% | 5 | Jul 2, 2025 | |
| EXEL Exelixis | Maintains: Buy | $47 → $53 | $45.59 | +16.25% | 9 | Jun 30, 2025 | |
| BNTX BioNTech SE | Reiterates: Buy | $138 | $110.63 | +24.74% | 43 | Jun 25, 2025 | |
| IMMX Immix Biopharma | Reiterates: Buy | $7 | $2.67 | +162.17% | 8 | Jun 4, 2025 | |
| YMAB Y-mAbs Therapeutics | Maintains: Buy | $12 → $11 | $4.34 | +153.46% | 21 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $44 → $41 | $9.68 | +323.55% | 4 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $2.35 | +411.73% | 3 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $39 → $40 | $21.75 | +83.91% | 9 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $73 → $72 | $38.64 | +86.34% | 20 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $22 | $11.16 | +97.13% | 24 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $18 | $4.08 | +341.72% | 2 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $0.86 | +484.32% | 16 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $3 | $1.66 | +81.27% | 14 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $6.06 | +114.52% | 12 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $12.32 | +192.21% | 15 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $8.20 | +21.95% | 7 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $3.24 | +146.91% | 21 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $4.06 | +146.31% | 3 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $4 → $2 | $1.63 | +23.08% | 21 | Mar 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.24 | +303.06% | 11 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $8 | $1.28 | +527.45% | 17 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $12 | $2.84 | +322.54% | 13 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $34 | $2.57 | +1,222.96% | 3 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $10 | $2.21 | +353.51% | 14 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $5 | $1.53 | +226.80% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.64 | +339.56% | 21 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.58 | - | 4 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $9.18 | - | 13 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $1.36 | +711.81% | 13 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $500 → $200 | $5.50 | +3,536.36% | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $110 → $20 | $0.61 | +3,165.31% | 2 | Mar 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.90 | - | 6 | Jan 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $2.22 | +6,656.76% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $1.40 | +1,471.43% | 4 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $115 → $7 | $1.16 | +506.06% | 7 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $11 | $2.41 | +356.43% | 1 | Dec 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $225 | $0.05 | +475,587.10% | 7 | Nov 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $25 | $3.51 | +612.25% | 1 | Jun 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $13 | $2.51 | +418.96% | 1 | Jan 7, 2021 |
Karyopharm Therapeutics
Jul 11, 2025
Assumes: Buy
Price Target: $27
Current: $4.60
Upside: +486.96%
Cogent Biosciences
Jul 8, 2025
Maintains: Buy
Price Target: $12 → $22
Current: $10.91
Upside: +101.65%
Replimune Group
Jul 3, 2025
Reiterates: Buy
Price Target: $22
Current: $10.85
Upside: +102.76%
Zymeworks
Jul 3, 2025
Reiterates: Neutral
Price Target: $13
Current: $13.49
Upside: -3.63%
Telix Pharmaceuticals
Jul 3, 2025
Initiates: Buy
Price Target: $23
Current: $15.93
Upside: +44.38%
Enliven Therapeutics
Jul 2, 2025
Maintains: Buy
Price Target: $40 → $48
Current: $22.39
Upside: +114.38%
Exelixis
Jun 30, 2025
Maintains: Buy
Price Target: $47 → $53
Current: $45.59
Upside: +16.25%
BioNTech SE
Jun 25, 2025
Reiterates: Buy
Price Target: $138
Current: $110.63
Upside: +24.74%
Immix Biopharma
Jun 4, 2025
Reiterates: Buy
Price Target: $7
Current: $2.67
Upside: +162.17%
Y-mAbs Therapeutics
May 19, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $4.34
Upside: +153.46%
May 16, 2025
Maintains: Buy
Price Target: $44 → $41
Current: $9.68
Upside: +323.55%
May 16, 2025
Reiterates: Buy
Price Target: $12
Current: $2.35
Upside: +411.73%
May 14, 2025
Maintains: Buy
Price Target: $39 → $40
Current: $21.75
Upside: +83.91%
May 14, 2025
Maintains: Buy
Price Target: $73 → $72
Current: $38.64
Upside: +86.34%
May 9, 2025
Maintains: Buy
Price Target: $21 → $22
Current: $11.16
Upside: +97.13%
May 9, 2025
Maintains: Buy
Price Target: $17 → $18
Current: $4.08
Upside: +341.72%
May 5, 2025
Reiterates: Buy
Price Target: $5
Current: $0.86
Upside: +484.32%
Apr 28, 2025
Maintains: Buy
Price Target: $9 → $3
Current: $1.66
Upside: +81.27%
Apr 14, 2025
Reiterates: Buy
Price Target: $13
Current: $6.06
Upside: +114.52%
Apr 2, 2025
Reiterates: Buy
Price Target: $36
Current: $12.32
Upside: +192.21%
Apr 2, 2025
Reiterates: Buy
Price Target: $10
Current: $8.20
Upside: +21.95%
Mar 31, 2025
Reiterates: Buy
Price Target: $8
Current: $3.24
Upside: +146.91%
Mar 31, 2025
Reiterates: Buy
Price Target: $10
Current: $4.06
Upside: +146.31%
Mar 25, 2025
Maintains: Neutral
Price Target: $4 → $2
Current: $1.63
Upside: +23.08%
Mar 20, 2025
Reiterates: Buy
Price Target: $5
Current: $1.24
Upside: +303.06%
Mar 19, 2025
Maintains: Buy
Price Target: $9 → $8
Current: $1.28
Upside: +527.45%
Mar 18, 2025
Maintains: Buy
Price Target: $11 → $12
Current: $2.84
Upside: +322.54%
Mar 18, 2025
Maintains: Buy
Price Target: $40 → $34
Current: $2.57
Upside: +1,222.96%
Mar 10, 2025
Maintains: Buy
Price Target: $11 → $10
Current: $2.21
Upside: +353.51%
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $5
Current: $1.53
Upside: +226.80%
Mar 7, 2025
Reiterates: Buy
Price Target: $16
Current: $3.64
Upside: +339.56%
Jan 30, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.58
Upside: -
Jan 28, 2025
Reiterates: Neutral
Price Target: n/a
Current: $9.18
Upside: -
Sep 5, 2024
Maintains: Neutral
Price Target: $12 → $11
Current: $1.36
Upside: +711.81%
May 8, 2024
Maintains: Buy
Price Target: $500 → $200
Current: $5.50
Upside: +3,536.36%
Mar 21, 2024
Maintains: Buy
Price Target: $110 → $20
Current: $0.61
Upside: +3,165.31%
Jan 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.90
Upside: -
Aug 8, 2023
Reiterates: Buy
Price Target: $150
Current: $2.22
Upside: +6,656.76%
Mar 17, 2023
Reiterates: Buy
Price Target: $22
Current: $1.40
Upside: +1,471.43%
Jan 24, 2023
Downgrades: Neutral
Price Target: $115 → $7
Current: $1.16
Upside: +506.06%
Dec 22, 2021
Maintains: Buy
Price Target: $12 → $11
Current: $2.41
Upside: +356.43%
Nov 24, 2021
Maintains: Buy
Price Target: $250 → $225
Current: $0.05
Upside: +475,587.10%
Jun 21, 2021
Assumes: Buy
Price Target: $25
Current: $3.51
Upside: +612.25%
Jan 7, 2021
Maintains: Buy
Price Target: $19 → $13
Current: $2.51
Upside: +418.96%